94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Albert Braeuning1*
Patrick Balaguer2
William Bourguet3
Jordi Carreras-Puigvert4Katreece Feiertag5
Jorke H. Kamstra6
Dries Knapen7Dajana Lichtenstein1
Philip Marx-Stoelting5Jonne Rietdijk4
Kristin Schubert8
Ola Spjuth4
Evelyn Stinckens7Kathrin Thedieck9Rik van den Boom7
Lucia Vergauwen7
Martin von Bergen8Neele Wewer1
Daniel Zalko10- 1Department of Food Safety, German Federal Institute for Risk Assessment, Berlin, Germany
- 2IRCM (Institut de Recherche en Cancérologie de Montpellier), Inserm U1194, Université de Montpellier, ICM, Montpellier, France
- 3CBS Centre de Biologie Structurale, Université de Montpellier, CNRS, Inserm, Montpellier, France
- 4Department of Pharmaceutical Biosciences and Science for Life Laboratory, Uppsala University, Uppsala, Sweden
- 5Department of Pesticides Safety, German Federal Institute for Risk Assessment, Berlin, Germany
- 6Department of Population Health Sciences, Institute for Risk Assessment Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands
- 7Zebrafishlab, Veterinary Physiology and Biochemistry, Department of Veterinary Sciences, University of Antwerp, Wilrijk, Belgium
- 8Department of Molecular Systems Biology, Helmholtz Centre for Environmental Research (UFZ), Leipzig, Germany
- 9Institute of Biochemistry and Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria
- 10Toxalim (Research Centre in Food Toxicology), Université de Toulouse, Institut National de Recherche Pour L’Agriculture, L’Alimentation et L’Environnement (INARE), Ecole Nationale Vétérinaire de Toulouse (ENVT), INP-Purpan, Université Paul Sabatier (UPS), Toulouse, France
A Corrigendum on
Development of new approach methods for the identification and characterization of endocrine metabolic disruptors—a PARC project
by Braeuning A, Balaguer P, Bourguet W, Carreras-Puigvert J, Feiertag K, Kamstra JH, Knapen D, Lichtenstein D, Marx-Stoelting P, Rietdijk J, Schubert K, Spjuth O, Stinckens E, Thedieck K, van den Boom R, Vergauwen L, von Bergen M, Wewer N and Zalko D (2023). Front. Toxicol. 5:1212509. doi: 10.3389/ftox.2023.1212509
In the published article, there was an error. In Section 5 an erroneous entry was introduced, indicating an opposite effect of what was shown in the reference referring to that entry.
A correction has been made to ‘5 Measures for obesogenic effects of MDCs’, paragraph 2. This sentence previously started:
“In contrast, in human bone marrow-derived mesenchymal stem cells (hMSCs), BPA alternatives attenuated adipogenesis (Norgren et al., 2022), stressing the importance to research mechanisms and variable exposure scenarios.”
The corrected sentence appears below:
“In contrast, in human bone marrow-derived mesenchymal stem cells (hMSCs), BPA alternatives induced adipogenesis (Norgren et al., 2022), stressing the importance to research mechanisms and variable exposure scenarios.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: endocrine metabolic disruption, energy metabolism, obesogens, nuclear receptors, adipocytes, liver
Citation: Braeuning A, Balaguer P, Bourguet W, Carreras-Puigvert J, Feiertag K, Kamstra JH, Knapen D, Lichtenstein D, Marx-Stoelting P, Rietdijk J, Schubert K, Spjuth O, Stinckens E, Thedieck K, van den Boom R, Vergauwen L, von Bergen M, Wewer N and Zalko D (2024) Corrigendum: Development of new approach methods for the identification and characterization of endocrine metabolic disruptors—a PARC project. Front. Toxicol. 6:1394396. doi: 10.3389/ftox.2024.1394396
Received: 01 March 2024; Accepted: 15 March 2024;
Published: 25 March 2024.
Edited and reviewed by:
Bengt Fadeel, Karolinska Institutet (KI), SwedenCopyright © 2024 Braeuning, Balaguer, Bourguet, Carreras-Puigvert, Feiertag, Kamstra, Knapen, Lichtenstein, Marx-Stoelting, Rietdijk, Schubert, Spjuth, Stinckens, Thedieck, van den Boom, Vergauwen, von Bergen, Wewer and Zalko. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Albert Braeuning, YWxiZXJ0LmJyYWV1bmluZ0BiZnIuYnVuZC5kZQ==